These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 10926326)

  • 21. p53 Protein expression in meningiomas - a clinicopathologic study of 55 patients.
    Aguiar PH; Agner C; Simm R; Freitas AB; Tsanaclis AM; Plese P
    Neurosurg Rev; 2002 Aug; 25(4):252-7. PubMed ID: 12172734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of p63 protein expression with histological grade of meningiomas: an immunohistochemical study.
    Mittal S; Jain D; Roy S; Mehta VS
    Int J Surg Pathol; 2012 Aug; 20(4):349-54. PubMed ID: 22287651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meningiomas: correlation of Ki67 with histological grade.
    Babu S; Uppin SG; Uppin MS; Panigrahi MK; Saradhi V; Bhattacharjee S; Sahu BP; Purohit AK; Challa S
    Neurol India; 2011; 59(2):204-7. PubMed ID: 21483118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of cell cycle regulatory proteins in oligodendroglial tumors.
    Kamiya M; Nakazato Y
    Clin Neuropathol; 2002; 21(2):52-65. PubMed ID: 12005253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of cathepsin D in meningiomas.
    Castilla EA; Prayson RA; Abramovich CM; Cohen ML
    Am J Clin Pathol; 2003 Jan; 119(1):123-8. PubMed ID: 12520707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma.
    Shayanfar N; Mashayekh M; Mohammadpour M
    Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Ki-67 and p53 in meningiomas.
    Pavelin S; Becic K; Forempoher G; Mrklic I; Pogorelic Z; Titlic M; Andelinovic S
    Neoplasma; 2013; 60(5):480-5. PubMed ID: 23790165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of expression of epidermal growth factor receptor and p53 in meningiomas.
    Narla S; Uppin MS; Saradhi MV; Sahu BP; Purohit AK; Sundaram C
    Neurol India; 2014; 62(1):37-41. PubMed ID: 24608452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study].
    Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
    Kleer CG; Giordano TJ; Braun T; Oberman HA
    Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Convexity meningiomas: study of recurrence factors with special emphasis on the cleavage plane in a series of 100 consecutive patients.
    Alvernia JE; Dang ND; Sindou MP
    J Neurosurg; 2011 Sep; 115(3):491-8. PubMed ID: 21663413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term surgical outcomes of spinal meningiomas.
    Nakamura M; Tsuji O; Fujiyoshi K; Hosogane N; Watanabe K; Tsuji T; Ishii K; Toyama Y; Chiba K; Matsumoto M
    Spine (Phila Pa 1976); 2012 May; 37(10):E617-23. PubMed ID: 22146282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry.
    Nakaguchi H; Fujimaki T; Matsuno A; Matsuura R; Asai A; Suzuki I; Sasaki T; Kirino T
    Cancer; 1999 May; 85(10):2249-54. PubMed ID: 10326705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An immunohistochemical study of HER2 expression in meningioma and its correlation with tumor grade.
    Mahzouni P; Movahedipour M
    Pathol Res Pract; 2012 Apr; 208(4):221-4. PubMed ID: 22420924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas.
    Ohkoudo M; Sawa H; Hara M; Saruta K; Aiso T; Ohki R; Yamamoto H; Maemura E; Shiina Y; Fujii M; Saito I
    J Neurooncol; 1998 May; 38(1):41-9. PubMed ID: 9540056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
    Korshunov A; Shishkina L; Golanov A
    Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.
    Oya S; Kawai K; Nakatomi H; Saito N
    J Neurosurg; 2012 Jul; 117(1):121-8. PubMed ID: 22559847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrence of meningiomas.
    Yamasaki F; Yoshioka H; Hama S; Sugiyama K; Arita K; Kurisu K
    Cancer; 2000 Sep; 89(5):1102-10. PubMed ID: 10964341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic LINAC radiosurgery for incompletely resected or recurrent atypical and anaplastic meningiomas.
    El-Khatib M; El Majdoub F; Hoevels M; Kocher M; Müller RP; Steiger HJ; Sturm V; Maarouf M
    Acta Neurochir (Wien); 2011 Sep; 153(9):1761-7. PubMed ID: 21706274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different responses of benign and atypical meningiomas to gamma-knife radiosurgery: report of two cases with immunohistochemical analysis.
    Kawashima M; Suzuki SO; Ikezaki K; Matsushima T; Fukui M; Iwaki T
    Brain Tumor Pathol; 2001; 18(2):61-6. PubMed ID: 11908875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.